Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $38.2 Million - $49.1 Million
-2,453,950 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $6.59 Million - $10.8 Million
-451,626 Reduced 15.54%
2,453,950 $37.8 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $636,664 - $775,425
-30,231 Reduced 1.03%
2,905,576 $62.6 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $9.06 Million - $13.4 Million
-540,541 Reduced 15.55%
2,935,807 $71.4 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $1.77 Million - $2.35 Million
-106,365 Reduced 2.97%
3,476,348 $59.4 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $40.2 Million - $68.4 Million
3,582,713
3,582,713 $67.9 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Jana Partners LLC Portfolio

Follow Jana Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jana Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jana Partners LLC with notifications on news.